Sage Bionetworks is guided by distinguished science and business leaders

Stephen H. Friend MD PhD

Stephen H. Friend MD PhD

President, Co-Founder and Director of Sage Bionetworks

Dr. Friend is the President of Sage Bionetworks. He was previously Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc. where he led Merck’s Basic Cancer Research efforts. In 2005, he led the Advanced Technologies and Oncology groups to firmly establish molecular profiling activities throughout Merck’s laboratories around the world, as well as to coordinate oncology programs from Basic Research through phase IIA clinical trials. Prior to joining Merck, Dr. Friend along with Dr. Leland Hartwell founded and co-led the Fred Hutchinson Cancer Research Center’s “Seattle Project”, an advanced institute for drug discovery. While there Drs. Friend and Hartwell developed a method for examining large patterns of genes that led them to co-found Rosetta Inpharmatics in 2001. Dr. Friend has also held faculty positions at Harvard Medical School from 1987 to 1995 and at Massachusetts General Hospital from 1990 to 1995. He received his B.A. in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.

Stephen H. Friend MD PhDEric E. Schadt PhD

Co-Founder, Director and Chair of Sage Bionetworks Scientific Advisory Board

Dr. Schadt is the Director of the Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences and the Jean C. and James W. Crystal Professor of Genomics at Mount Sinai School of Medicine. He is an industry leader in network biology with a number of high-profile publications over the past 5 years and is the Editor-in-Chief of the new journal Open Network Biology. Dr. Schadt helped start Sage Bionetworks while Executive Scientific Director, Genetics at Rosetta Inpharmatics where he founded its Research Genetics Department after Rosetta was acquired by Merck in 2001. His extensive applications in systems biology have helped define the genetics of gene expression as a new field in statistical genetics. Prior to joining Rosetta Dr. Schadt was a Senior Research Scientist at Roche Bioscience. He received his B.S. in applied mathematics/computer science from California Polytechnic State University, and his M.A. in pure mathematics and his Ph.D. in bio-mathematics from UCLA.

Tony Ford-HutchinsonAnthony W. Ford-Hutchinson PhD

Director of Sage Bionetworks

Dr. Ford-Hutchinson is Senior Vice President, Vaccines Research and Development Merck Research Laboratories. He has a 30 year record of success at Merck & Co., Inc. and was Senior Vice President and Site Head of Merck Frosst Canada during the development of Singulair® for the treatment of adult and pediatric asthma and allergic rhinitis and the discovery of selective COX-2 inhibitors for the treatment of osteoarthritis and pain. Before joining Merck he was a lecturer in the Chemical Pathology Department at Kings College Hospital Medical School in London doing leukotriene and prostaglandin research. Dr. Ford-Hutchinson obtained his Bachelor’s Degree in Biochemistry from the University of Birmingham, a Masters Degree in Molecular Enzymology from the University of Warwick, and a Ph.D. in Biochemistry from the University of London.

Jeff HammerbacherJeff Hammerbacher

Director of Sage Bionetworks

Jeff Hammerbacher is a founder and the Chief Scientist of Cloudera. Jeff was an Entrepreneur in Residence at Accel Partners immediately prior to founding Cloudera. Before Accel, he conceived, built, and led the Data team at Facebook. The Data team was responsible for driving many of the applications of statistics and machine learning at Facebook, as well as building out the infrastructure to support these tasks for massive data sets. The Data team produced open source projects such as Hive and Cassandra and their work was recognized at conferences such as CHI, ICWSM, SIGMOD, and VLDB. Before joining Facebook, Jeff was a quantitative analyst on Wall Street. Jeff earned his Bachelor's Degree in Mathematics from Harvard University and recently served as a Contributing Editor for O'Reilly's "Beautiful Data".

Jun Wang PhDJun Wang PhD

Director of Sage Bionetworks

Dr. Wang is the Executive Director of the BGI (previously known as the Beijing Genomics Institute). He was instrumental in the 1999 founding and the growth of the BGI Bioinformatics Department, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. Dr. Wang also holds a position as an Ole Rømer professor at the University of Copenhagen. He has been recognized with an award from His Royal Highness Prince Foundation in Denmark, an Outstanding Science and Technology Achievement from the Chinese Academy of Sciences, Top 10 Scientific Achievements in China, and the prize for Important Innovation and Contribution from the Chinese Academy of Sciences. His research focuses on genomics and related bioinformatics analysis of common diseases and agricultural crops, with the goal of developing applications using this genomic information.

Stephen H. Friend MD PhDHans Wigzell MD DSc

Director of Sage Bionetworks

Professor Wigzell was President of the Karolinska Institute from 1995 to 2003. He was elected Chairman of the European Union Concerted Research Programme into AIDS vaccination in 1990. In 1993 he was appointed Secretary-General of the Swedish Institute for Infectious Disease Control and has been a Chief Scientific Advisor to the Swedish Government and one of eleven appointed advisors on life science issues to the European Union Commissioner for Research. Professor Wigzell was appointed Chairman of the Nobel Assembly in 2000 and in 2002 he was appointed Chairman for the WHO-UNAIDS Vaccine Advisory Committee. Professor Wigzell received his MD and DSc from the Karolinska Institute and then joined the Swedish Cancer Society as a Special Cancer Scientist. He subsequently held senior faculty positions in the Department of Tumor Biology at the Karolinska Institute and in the Department of Immunology at Uppsala University Medical School. In 1982 he returned to the Karolinska as a Professor in the Department of Immunology and in 1988 became Director General of the National Bacteriological Laboratory in Stockholm. Professor Wigzell is an elected member of the Royal Swedish Academy of Sciences, the Royal Swedish Academy of Engineering Sciences, the Finnish Society of Sciences and Letters, the Danish Academy of Sciences and Letters, EMBO, Academia Europea, and honorary member of the American Society for Immunology. Professor Wigzell has been awarded a number of prizes including the Anders Jahre Medical Prize, the Erik Fernström’s Prize for Young Scientists, the Russel Weiser Lecturer Prize and the Smith Lecture Award.

Stephen H. Friend MD PhDJohn Wilbanks

Director of Sage Bionetworks

John Wilbanks is a Fellow of the Ewing Marion Kauffman Foundation. He was previously Vice President of Science at Creative Commons following a fellowship at the World Wide Web Consortium in Semantic Web for Life Sciences. Previously, he founded and led Incellico, a bioinformatics company that built semantic graph networks for use in pharmaceutical research & development. Previously he was the Assistant Director at the Berkman Center for Internet and Society at Harvard Law School and also worked as a legislative aide to U.S. Representative Fortney (Pete) Stark. Mr. Wilbanks received a BA in Philosophy from Tulane University and studied modern letters at the Universite de Paris IV (La Sorbonne). He is an editorial board member of Open Network Biology and a research affiliate at the MIT Computer Science and Artificial Intelligence Laboratory in the project on Mathematics and Computation and serves on the Advisory Boards of the U.S. National Library of Medicine’s PubMed Central, the Open Knowledge Foundation, the Open Knowledge Definition, and the International Advisory Board of the Prix Ars Electronica’s Digital Communities awards. He also serves on the Board of Directors of the Fedora Commons digital repository organization.

^ Back to top